Woodline Partners’s Upstream Bio UPB Stock Holding History
Bought
Maintained
Sold
Other funds holding UPB
Woodline Partners's UPB Position: Q3 2026 in Review
Woodline Partners held its Upstream Bio (UPB) position steady in Q3 2026 at 831,481 shares worth $4.38M. The position accounts for 0.01% of the portfolio, ranked #748.
Woodline Partners first reported a position in UPB in Q4 2024 and has held it in 8 quarters since. The position peaked at $20.6M in Q4 2025. 135 funds tracked by Wall St. Rank hold UPB as of Q3 2026.
- Woodline Partners held 831,481 shares of Upstream Bio worth $4.38M as of Q3 2026.
- Woodline Partners left its Upstream Bio share count unchanged in Q3 2026.
- Upstream Bio made up 0.01% of Woodline Partners's portfolio in Q3 2026, its #748 holding.
- Woodline Partners first reported a position in Upstream Bio in Q4 2024 and has held it in 8 quarters since.
- Woodline Partners's Upstream Bio position peaked at $20.6M in Q4 2025.
- 135 funds tracked by Wall St. Rank held Upstream Bio as of Q3 2026.
Based on Woodline Partners's 13F filing for Q3 2026, filed 16 Nov 2026.